MFS
CMPX icon

Mirabella Financial Services’s Compass Therapeutics CMPX Stock Holding History

Mirabella Financial Services’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,444
Closed -$153K – 421
2022
Q4 		$153K Buy
+30,444
New +$121K 0.01% 332
2022
Q1 		– Sell
-18,880
Closed -$60K – 559
2021
Q4 		$60K Buy
+18,880
New +$62.6K 0.01% 377

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mirabella Financial Services's CMPX Position: Q1 2023 in Review

Mirabella Financial Services sold out of Compass Therapeutics (CMPX) in Q1 2023, closing a stake of 30,444 shares — an estimated $153K sold.

Mirabella Financial Services first reported a position in CMPX in Q4 2021 and held it in 2 quarters. The position peaked at $153K in Q4 2022. 72 funds tracked by Wall St. Rank hold CMPX as of Q1 2023.

  • Mirabella Financial Services reported no remaining Compass Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 30,444 Compass Therapeutics shares in Q1 2023, an estimated $153K.
  • Mirabella Financial Services first reported a position in Compass Therapeutics in Q4 2021 and held it in 2 quarters.
  • Mirabella Financial Services's Compass Therapeutics position peaked at $153K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2023.

Based on Mirabella Financial Services's 13F filing for Q1 2023, filed 12 May 2023.